
MYSZ Valuation
My Size Inc
- Overview
- Forecast
- Valuation
- Earnings
MYSZ Relative Valuation
MYSZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MYSZ is overvalued; if below, it's undervalued.
Historical Valuation
My Size Inc (MYSZ) is now in the Overvalued zone, suggesting that its current forward PS ratio of 0.35 is considered Overvalued compared with the five-year average of -1.13. The fair price of My Size Inc (MYSZ) is between 0.54 to 1.08 according to relative valuation methord. Compared to the current price of 1.20 USD , My Size Inc is Overvalued By 10.96%.
Relative Value
Fair Zone
0.54-1.08
Current Price:1.20
10.96%
Overvalued
-0.46
PE
1Y
3Y
5Y
Trailing
Forward
0.28
EV/EBITDA
My Size Inc. (MYSZ) has a current EV/EBITDA of 0.28. The 5-year average EV/EBITDA is -0.38. The thresholds are as follows: Strongly Undervalued below -2.56, Undervalued between -2.56 and -1.47, Fairly Valued between 0.71 and -1.47, Overvalued between 0.71 and 1.80, and Strongly Overvalued above 1.80. The current Forward EV/EBITDA of 0.28 falls within the Historic Trend Line -Fairly Valued range.
-0.20
EV/EBIT
My Size Inc. (MYSZ) has a current EV/EBIT of -0.20. The 5-year average EV/EBIT is -0.47. The thresholds are as follows: Strongly Undervalued below -2.02, Undervalued between -2.02 and -1.24, Fairly Valued between 0.30 and -1.24, Overvalued between 0.30 and 1.08, and Strongly Overvalued above 1.08. The current Forward EV/EBIT of -0.20 falls within the Historic Trend Line -Fairly Valued range.
0.37
PS
My Size Inc. (MYSZ) has a current PS of 0.37. The 5-year average PS is 10.84. The thresholds are as follows: Strongly Undervalued below -31.78, Undervalued between -31.78 and -10.47, Fairly Valued between 32.15 and -10.47, Overvalued between 32.15 and 53.46, and Strongly Overvalued above 53.46. The current Forward PS of 0.37 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
My Size Inc. (MYSZ) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
My Size Inc. (MYSZ) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
My Size Inc (MYSZ) has a current Price-to-Book (P/B) ratio of 0.43. Compared to its 3-year average P/B ratio of 0.56 , the current P/B ratio is approximately -22.25% higher. Relative to its 5-year average P/B ratio of 1.40, the current P/B ratio is about -69.08% higher. My Size Inc (MYSZ) has a Forward Free Cash Flow (FCF) yield of approximately -79.22%. Compared to its 3-year average FCF yield of -213.18%, the current FCF yield is approximately -62.84% lower. Relative to its 5-year average FCF yield of -153.51% , the current FCF yield is about -48.39% lower.
0.43
P/B
Median3y
0.56
Median5y
1.40
-76.67
FCF Yield
Median3y
-213.18
Median5y
-153.51
Competitors Valuation Multiple
The average P/S ratio for MYSZ's competitors is 0.13, providing a benchmark for relative valuation. My Size Inc Corp (MYSZ) exhibits a P/S ratio of 0.37, which is 173.59% above the industry average. Given its robust revenue growth of -50.44%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MYSZ decreased by 35.48% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -34.05 to -71.67.
The secondary factor is the Revenue Growth, contributed -50.44%to the performance.
Overall, the performance of MYSZ in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

SNOA
Sonoma Pharmaceuticals Inc
3.020
USD
+0.33%

TTNP
Titan Pharmaceuticals Inc
3.930
USD
+0.26%

OST
Ostin Technology Group Co Ltd
1.770
USD
-17.29%

NBY
NovaBay Pharmaceuticals Inc
0.591
USD
-3.27%

ZVSA
Zyversa Therapeutics Inc
0
USD
-76.45%

ASTI
Ascent Solar Technologies Inc
1.930
USD
+12.21%

NIVF
NewGenIvf Group Ltd
1.910
USD
-14.73%

INM
InMed Pharmaceuticals Inc
2.270
USD
-1.73%
FAQ

Is My Size Inc (MYSZ) currently overvalued or undervalued?
My Size Inc (MYSZ) is now in the Overvalued zone, suggesting that its current forward PS ratio of 0.35 is considered Overvalued compared with the five-year average of -1.13. The fair price of My Size Inc (MYSZ) is between 0.54 to 1.08 according to relative valuation methord. Compared to the current price of 1.20 USD , My Size Inc is Overvalued By 10.96% .

What is My Size Inc (MYSZ) fair value?

How does MYSZ's valuation metrics compare to the industry average?

What is the current P/B ratio for My Size Inc (MYSZ) as of Aug 07 2025?

What is the current FCF Yield for My Size Inc (MYSZ) as of Aug 07 2025?

What is the current Forward P/E ratio for My Size Inc (MYSZ) as of Aug 07 2025?
